Clinical Trial Update: Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set [Phase 1]

View source ↗

Summary

Phase 1 study evaluating extended wear of the Medtronic Sof-set infusion set for people with Type 1 diabetes; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Medtronic Extended Wear Sof-set Infusion Set

Snippet

Sponsor: Stanford University | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED